Trulieve Cannabis Corp.
TCNNF
$5.42
-$0.06-1.10%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.37% | -0.45% | 0.05% | 4.94% | 3.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.37% | -0.45% | 0.05% | 4.94% | 3.30% |
| Cost of Revenue | 6.60% | -2.16% | -7.49% | -14.27% | -16.07% |
| Gross Profit | -1.97% | 0.70% | 5.42% | 21.56% | 21.22% |
| SG&A Expenses | -33.38% | -1.43% | 17.24% | 64.02% | 58.36% |
| Depreciation & Amortization | 3.97% | 4.81% | 5.67% | 5.30% | 5.10% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.29% | -1.09% | 3.86% | 17.18% | 13.79% |
| Operating Income | 1,225.12% | 2.74% | -21.50% | -98.55% | -116.62% |
| Income Before Tax | 328.25% | 6.57% | -36.37% | -246.25% | -193.54% |
| Income Tax Expenses | 11.93% | 15.93% | -5.36% | 4.72% | 29.32% |
| Earnings from Continuing Operations | 60.59% | -47.91% | -36.82% | -65.21% | -162.79% |
| Earnings from Discontinued Operations | -208.62% | 81.78% | -19.44% | -160.07% | 44.11% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 18.62% | 720.77% | -49.72% | 30.76% | 264.30% |
| Net Income | 55.43% | -14.57% | -42.42% | -78.83% | -137.13% |
| EBIT | 1,225.12% | 2.74% | -21.50% | -98.55% | -116.62% |
| EBITDA | 123.36% | 3.41% | -8.92% | -40.91% | -40.31% |
| EPS Basic | 57.15% | 27.68% | -41.22% | -77.90% | -143.60% |
| Normalized Basic EPS | 316.14% | 10.45% | -30.13% | -175.42% | -383.93% |
| EPS Diluted | 57.15% | 27.68% | -41.22% | -77.90% | -143.60% |
| Normalized Diluted EPS | 316.14% | 10.45% | -30.13% | -175.42% | -383.93% |
| Average Basic Shares Outstanding | 0.57% | 0.46% | 0.86% | 0.53% | 0.67% |
| Average Diluted Shares Outstanding | 0.57% | 0.46% | 0.86% | 0.53% | 0.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |